Identification of Matrix Metalloproteinase 11 as a Prognostic Biomarker in Pancreatic Cancer
Posted by Corey Marcath on
Single Donor Human Whole Blood from Innovative Research was used in the following study:
Identification of Matrix Metalloproteinase 11 as a Prognostic Biomarker in Pancreatic Cancer
JUNGWHOI LEE, JUNGSUL LEE and JAE HOON KIM
Anticancer Research
11/1/2019
“…The aim of this study was to investigate matrix metalloproteinase 11 (MMP11) as a promising biomarker in human pancreatic cancer. …Whole blood samples collection. A total of 12 different whole blood samples from pancreatic cancer patients and 16 different samples from healthy donors were purchased from Innovative (21) (Novi, MI, USA)…”
Related products available from Innovative Research also include:
Innovative Research was established in 1998 after the realization that dependable, high-quality, and affordable research materials were hard to come by. Starting with core products like human plasma and serum, Innovative Research has grown to be a trusted supplier of all lab reagents, including human biologicals and ELISA kits. Today, we manufacture and supply thousands of high-quality human and animal biologicals including plasma, serum, tissues, and proteins.
Related Posts
We have biological products and research materials to assist with early phase next gen COVID vaccine research
This autumn, as clinical trials get underway to evaluate the effectiveness of the most ...
Read the ArticleMonoclonal Antibody to VLDLR (MA-1H10): An Explainer
The Innovative Research lab pulled together an explainer on one of our recently popular...
Read the ArticleUpdate Post: A Timeline of Hemophilia Research
Hemophilia is a bleeding disorder in which the body is unable to form blood clots prope...
Read the Article